We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intervention Toward Truth-Telling and Advanced Directives in the Patient With Advanced or Metastatic Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00792896
Recruitment Status : Unknown
Verified May 2008 by National Taiwan University Hospital.
Recruitment status was:  Recruiting
First Posted : November 18, 2008
Last Update Posted : November 18, 2008
Sponsor:
Collaborator:
Information provided by:

Study Description
Brief Summary:
Family usually had a lot of burden to tell the truth to patients. The purpose of this study is to assess the effect of education materials and family conference for advanced cancer patients and family.

Condition or disease Intervention/treatment
Advanced Cancer Metastatic Cancer Behavioral: family conference

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 150 participants
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Longitudinal Study That Assessed the Effectiveness of Intervention Toward
Study Start Date : May 2008
Estimated Primary Completion Date : December 2010
Arms and Interventions

Arm Intervention/treatment
Experimental: 1
Family conference + education materials
Behavioral: family conference
family conference
No Intervention: 2
education materials


Outcome Measures

Primary Outcome Measures :
  1. Questionnaires [ Time Frame: before and 1 week after the intervention ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • advanced or metastatic cancer patients
  • more than 20 years old
  • clear consciousness and be able to communicate

Exclusion Criteria:

  • refuse to know the statement of himself/herself disease
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00792896


Contacts
Contact: We-Yu Hu, Ph.D 23123456 ext 88428 weyuhu@ntu.edu.tw

Locations
Taiwan
National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: We-Yu Hu, Ph.D    23123456 ext 88428    weyuhu@ntu.edu.tw   
Principal Investigator: We-Yu Hu, Ph.D         
Sponsors and Collaborators
National Taiwan University Hospital
National Science Council, Taiwan
More Information

Responsible Party: 1, Jen-Ai Road Section 1, Taipei, Taiwan, Department of Nursing
ClinicalTrials.gov Identifier: NCT00792896     History of Changes
Other Study ID Numbers: 200803051R
First Posted: November 18, 2008    Key Record Dates
Last Update Posted: November 18, 2008
Last Verified: May 2008

Additional relevant MeSH terms:
Neoplasm Metastasis
Neoplastic Processes
Neoplasms
Pathologic Processes